RetinaAI

Test for AMD
#AI / data analytics / healthtech / informatics #Boehringer Ingelheim #Collaboration #Geographic atrophy #Partnership #RetinaAI

Partners use AI tools to advance novel drugs for geographic atrophy

A partnership between RetinAI Medical and Boehringer Ingelheim aims to improve patient outcomes in geographic atrophy (GA) by combining RetinAI’s Discovery platform and AI tools with Boehringer Ingelheim’s research in retinal diseases. GA is a progressive, advanced form of age-related macular degeneration and a leading cause of complete loss of… Read More

#Business & Investment #News